重症肌无力眼肌麻痹患者主要为眼肌型。
目的探讨眼肌型重症肌无力的临床特点及治疗。
Objective To observe the clinical manifestations and treatment of ocular myasthenia gravis.
目的：观察中药治疗眼肌型重症肌无力的临床疗效。
Objective: To observe the curative effect of TCM therapy on myasthenia gravis of ocular type.
有资料证实应用免疫抑制疗法减少了眼肌型患者进展成全身型的频率。
Some data show that immune depressive therapy can decrease the frequency of changes from ocular type to generalized type.
揭示联合用药治疗眼肌型重症肌无力治愈率高，减少了用药量和药物并发症，复发率低，应作为本病的首选治疗方法。
Ocular myopathy myasthenia gravis which had a higher success rate, few complications, lower re1apse rate and may be the first method.
揭示联合用药治疗眼肌型重症肌无力治愈率高，减少了用药量和药物并发症，复发率低，应作为本病的首选治疗方法。
Ocular myopathy myasthenia gravis which had a higher success rate, few complications, lower re1apse rate and may be the first method.
应用推荐